Latest News

Keep up to date with the latest news from our team at the Kolling Institute of Medical Research. By subscribing to our newsletter, you’ll discover more about our dedicated teams and their latest findings. You’ll have access to information about upcoming events and you’ll hear about opportunities to support our research.


Newsletter

Newsletter

Read more

Category: Newsletters

World-first discovery

World-first discovery

Kolling Institute scientist Dr Yo Otsu and a team of researchers have discovered a unique receptor in the brain which can regulate negative moods. The finding is the culmination of eight years of painstaking investigation, involving Dr Otsu and researchers from France, Canada and Hungary. The research has been published in the top academic journal Science, highlighting the discovery of ..... Read more

Category: Research Excellence

Newsletter

Newsletter

Read more

Category: Newsletters

Recognition for research excellence

Recognition for research excellence

Congratulations to Professor David Hunter who’s received a prestigious University of Sydney Vice Chancellor’s award for outstanding research. The Kolling researcher and rheumatology clinician is regarded as the world’s leading expert in osteoarthritis. Professor Hunter’s research has had a significant and lasting impact in the field of osteoarthritis, influencing clinical practice and a..... Read more

Category: Awards, New Treatment

Research identifies health impact of traffic accidents

Research identifies health impact of traffic accidents

More than 40 per cent of people injured in a traffic accident are psychologically distressed one month after their accident, with many of those suffering depression and post-traumatic stress symptoms. The research forms part of the latest findings into the physical and emotional impact of motor vehicle crash injuries by the team from the John Walsh Centre for Rehabilitation Research. Fro..... Read more

Category: Research Excellence

Delivering presentations people remember

Delivering presentations people remember

Kolling Institute cancer researchers were given an opportunity to spend the day with presenter Julie McCrossin. Julie spent more than 20 years as a radio broadcaster and is now a freelance journalist, facilitator, trainer and speaker. Julie invests a large share of her time supporting research initiatives, and in recent years has received treatment for head and neck cancer. Julie delive..... Read more

Category: Presentations

Kolling researchers part of elite group in fight against heart disease

Kolling researchers part of elite group in fight against heart disease

Two Kolling Institute researchers have welcomed a significant funding boost through a large NSW Government program to help tackle Australia’s number one killer, heart disease. Professors Gemma Figtree and Martin Ugander have each been awarded a $750,000 grant to encourage researchers to find breakthroughs and help establish NSW as a centre for research excellence. The funding is part of..... Read more

Category: Funding support

Northern Sydney leading the way with arthritis research and clinical care

Northern Sydney leading the way with arthritis research and clinical care

The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the diseas..... Read more

Category: New Treatment

Recognition for the Kolling Director

Recognition for the Kolling Director

The Kolling’s Director of Research Professor Carolyn Sue has been awarded a Member of the Order of Australia (AM) in this year’s Queen’s Birthday Honours for her significant service to medicine, particularly mitochondrial disease. Carolyn is a highly accomplished neurologist and is internationally regarded for her work in both Parkinson’s and mitochondrial disease. Recently appointed to ..... Read more

New world leading technology to guide future bowel cancer treatment

New world leading technology to guide future bowel cancer treatment

Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer. Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best analytical facilities in the worl..... Read more

Category: World-leading technology, New Treatment